NewAmsterdam Pharma Company N.V. Ordinary SharesEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 27.98 USD | 42,205 USD | 21,135 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 50,838 USD | 5 | 4 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 116.903.979 | 9,22 | 8,63 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name NewAmsterdam Pharma Company N.V. Ordinary Shares
Mitarbeiter 100
Handelsplatz NASDAQ
Ticker Symbol NAMS
IPO Datum 2022-11-23
Adresse Gooimeer 2-35, Naarden, Netherlands, 1411 DC
Webseite https://www.newamsterdampharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Michael Harvey Davidson FACC, Facp., M.D. | CEO, President & Executive Director |
| 2 | Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D. | Founder, Chief Scientific Officer, Member of Executive Board & Director |
| 3 | Mr. Mayur Amrat Somaiya | Chief Financial Officer |
| 4 | Mr. Douglas F. Kling | Chief Operating Officer |
| 5 | Ms. Louise Kooij | Chief Accounting Officer |
| 6 | Mr. Matthew Philippe | Executive VP & Head of Investor Relations |
| 7 | Mr. Michael F. Marino Esq. | Chief Legal Officer & Corporate Secretary |
| 8 | Mr. Chris Deluzio | Executive Vice President of Sales Enterprise Operations |
| 9 | Ms. Maryellen McQuade | Chief People Officer |
| 10 | Ms. Juliette Audet M.B.A., M.Sc. | Chief Strategy & Business Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |
| 2 | Capital World Investors | 0,00% | 0,00 Mio. USD |
| 3 | RA Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | FCPM III SERVICES BV | 0,00% | 0,00 Mio. USD |
| 5 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 6 | Bain Capital Life Sciences Investors, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 8 | Deerfield Management Co | 0,00% | 0,00 Mio. USD |
| 9 | Viking Global Investors LP | 0,00% | 0,00 Mio. USD |
| 10 | Duquesne Family Office LLC | 0,00% | 0,00 Mio. USD |
| 11 | Polar Capital Holdings PLC | 0,00% | 0,00 Mio. USD |
| 12 | Jennison Associates LLC | 0,00% | 0,00 Mio. USD |
| 13 | Medicxi Ventures Management (Jersey) Ltd | 0,00% | 0,00 Mio. USD |
| 14 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 15 | Westfield Capital Management Company, L.P. | 0,00% | 0,00 Mio. USD |
| 16 | Maverick Capital Ltd | 0,00% | 0,00 Mio. USD |
| 17 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 18 | Capital Research & Mgmt Co - Division 3 | 0,00% | 0,00 Mio. USD |
| 19 | AllianceBernstein L.P. | 0,00% | 0,00 Mio. USD |
| 20 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |